Total Payments
$14,400
2024 Payments
$3,947
Companies
43
Transactions
341
Medicare Patients
23,222
Medicare Billing
$3.8M
Payment Breakdown by Category
Food & Beverage$7,788 (54.1%)
Other$6,167 (42.8%)
Travel$295.30 (2.1%)
Education$149.80 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,788 | 332 | 54.1% |
| Grant | $6,125 | 2 | 42.5% |
| Travel and Lodging | $295.30 | 1 | 2.1% |
| Education | $149.80 | 4 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.64 | 1 | 0.2% |
| Entertainment | $17.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $6,266 | 5 | $0 (2024) |
| Penumbra, Inc. | $940.55 | 3 | $0 (2019) |
| Abbott Laboratories | $637.89 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $577.98 | 37 | $0 (2024) |
| Amgen Inc. | $491.11 | 32 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $401.80 | 15 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $391.44 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $369.91 | 22 | $0 (2024) |
| Boston Scientific Corporation | $341.16 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $334.37 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,947 | 56 | Medtronic, Inc. ($2,500) |
| 2023 | $4,856 | 49 | Medtronic, Inc. ($3,732) |
| 2022 | $1,300 | 66 | Abbott Laboratories ($216.40) |
| 2021 | $897.61 | 39 | Abbott Laboratories ($191.90) |
| 2020 | $487.99 | 22 | Esperion Therapeutics, Inc. ($144.76) |
| 2019 | $1,503 | 35 | Penumbra, Inc. ($935.55) |
| 2018 | $666.90 | 34 | Medtronic USA, Inc. ($125.00) |
| 2017 | $741.59 | 40 | Medtronic Vascular, Inc. ($129.10) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $29.58 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $32.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/11/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Vascular | ||||||
| 11/07/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $55.10 | General |
| Category: DEVICES | ||||||
| 10/29/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $10.86 | General |
| Category: Medical Device | ||||||
| 10/22/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $35.57 | General |
| Category: Medical Device | ||||||
| 10/18/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $37.11 | General |
| Category: DEVICES | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $27.33 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: Not Applicable | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Vascular | ||||||
| 08/13/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $35.57 | General |
| Category: Medical Device | ||||||
| 08/08/2024 | Silk Road Medical, Inc. | ENROUTE Transcarotid Stent (Device), ENROUTE Transcarotid Neuroprotection System, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/26/2024 | Medtronic, Inc. | — | Grant | Cash or cash equivalent | $2,500.00 | General |
| 07/25/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.17 | General |
| 07/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/11/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $33.74 | General |
| Category: Medical Device | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 5,956 | 21,185 | $2.2M | $983,947 |
| 2022 | 33 | 5,020 | 21,574 | $1.8M | $789,655 |
| 2021 | 34 | 5,649 | 25,202 | $1.9M | $882,596 |
| 2020 | 39 | 6,597 | 28,542 | $2.5M | $1.2M |
Total Patients
23,222
Total Services
96,503
Medicare Billing
$3.8M
Procedure Codes
145
All Medicare Procedures & Services
145 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 585 | 590 | $436,600 | $198,355 | 45.4% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 33 | 33 | $198,000 | $110,263 | 55.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 584 | 1,177 | $261,294 | $106,065 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 465 | 1,017 | $172,890 | $94,914 | 54.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 582 | 621 | $217,350 | $90,264 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 354 | 659 | $184,400 | $88,631 | 48.1% |
| 78481 | Nuclear medicine study of heart pumping function with measurement of internal blood volume ejected with every beat over a single cycle | Office | 2023 | 549 | 554 | $152,904 | $69,800 | 45.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 330 | 331 | $99,300 | $43,208 | 43.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 585 | 593 | $88,950 | $28,741 | 32.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 125 | 128 | $38,400 | $23,334 | 60.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 155 | 620 | $74,400 | $20,526 | 27.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 139 | $22,240 | $13,397 | 60.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $24,180 | $13,100 | 54.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 15 | 18 | $18,000 | $8,336 | 46.3% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 111 | 112 | $20,160 | $8,298 | 41.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 483 | 709 | $21,270 | $7,664 | 36.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 53 | $16,430 | $7,443 | 45.3% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 28 | 28 | $17,920 | $6,915 | 38.6% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 45 | 198 | $16,236 | $5,466 | 33.7% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 285 | 12,762 | $51,048 | $5,179 | 10.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 80 | $8,613 | $5,125 | 59.5% |
| 36252 | Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | Facility | 2023 | 33 | 33 | $19,800 | $4,900 | 24.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 45 | 198 | $13,365 | $3,984 | 29.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 40 | 66 | $5,676 | $3,742 | 65.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 24 | 24 | $6,620 | $3,105 | 46.9% |
About Dr. Hiren Patel, MD
Dr. Hiren Patel, MD is a Cardiovascular Disease healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114951225.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hiren Patel, MD has received a total of $14,400 in payments from pharmaceutical and medical device companies, with $3,947 received in 2024. These payments were reported across 341 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,788).
As a Medicare-enrolled provider, Patel has provided services to 23,222 Medicare beneficiaries, totaling 96,503 services with total Medicare billing of $3.8M. Data is available for 4 years (2020–2023), covering 145 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Port Charlotte, FL
- Active Since 07/11/2006
- Last Updated 11/28/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1114951225
Products in Payments
- Indigo (Device) $935.55
- BRILINTA (Drug) $435.43
- Kerendia (Drug) $401.80
- Repatha (Biological) $398.62
- LifeVest (Device) $391.44
- MULTAQ (Drug) $318.17
- ENTRESTO (Drug) $254.90
- XARELTO (Drug) $222.42
- Vascepa (Drug) $198.12
- Rhythmia Mapping System (Device) $195.22
- Impella (Device) $193.95
- VERQUVO (Drug) $184.06
- ELIQUIS (Drug) $172.95
- (5091) Amb Mon & Diag Und (Device) $159.96
- NEXLETOL (Drug) $154.51
- (CM9) Amb Mon & Diag Und (Device) $149.49
- NEXLIZET (Drug) $147.54
- JARDIANCE (Drug) $141.88
- Barostim Neo System (Device) $128.26
- KYPHON Balloon Kyphoplasty (Device) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Port Charlotte
Dr. David Hotchkiss, M.d, M.D
Cardiovascular Disease — Payments: $54,020
Cardiovascular Disease $54,020
Dr. Satish Velagapudi, M.d, M.D
Cardiovascular Disease — Payments: $31,569
Cardiovascular Disease $31,569
Nicolai Mejevoi, Md, MD
Cardiovascular Disease — Payments: $16,483
Cardiovascular Disease $16,483
Dr. Paul Popper, M.d, M.D
Cardiovascular Disease — Payments: $9,341
Cardiovascular Disease $9,341
Dr. Frederick Yturralde, M.d, M.D
Cardiovascular Disease — Payments: $7,085
Cardiovascular Disease $7,085
Louis Rosenfield, M.d, M.D
Cardiovascular Disease — Payments: $5,176
Cardiovascular Disease $5,176